Literature DB >> 27620744

A let-7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population.

Hasan Raza Kazmi1,2, Abhijit Chandra3, Saket Kumar1, Leena Khare Satyam4, Annapurna Gupta5, Jaya Nigam1, Meenu Srivastava1, Balraj Mittal5.   

Abstract

PURPOSE: Gallbladder cancer is a lethal malignancy of hepato-biliary system with high incidence in North India, especially along gangetic plain. The let-7 microRNAs play a key role in regulating KRAS expression and a polymorphism in 3' untranslated region (rs61764370, T/G) of KRAS leads to its higher expression. This polymorphism is known to be associated with increased risk and prognosis of various cancers but its association with gallbladder cancer has not been evaluated. To address this research question, we evaluated whether rs61764370 variant is associated with gallbladder cancer susceptibility and clinical outcomes.
METHODS: In present case-control study, we enrolled 541 patients with gallbladder malignancy and 307 controls. Genomic DNA was obtained from peripheral blood and genotyping was performed using Taqman allelic discrimination assay.
RESULTS: Heterozygous (TG) individuals are at a significant higher risk for GBC as compared with wild genotype (TT) (p = 0.007, odds ratio = 2.56, 95 % CI 1.27-5.18). At allelic level, allele G has significant higher risk for GBC as compared with T allele (p = 0.008, odds ratio = 2.5, 95 % CI 1.25-5.01). Survival analysis reveals decrease in overall survival for heterozygous genotype (p < 0.0001, hazard ratio = 3.42, 95 % CI 1.21-4.20). Also, significant decrease in overall survival was observed for patient carrying allele G (p < 0.0001, HR = 2.89, 95 % CI 1.21-4.20) as compared with allele C.
CONCLUSIONS: We conclude that KRAS rs61764370 polymorphism is significantly associated with risk and prognosis of gallbladder malignancy in this endemic belt.

Entities:  

Keywords:  Gallbladder cancer; KRAS; let-7; rs61764370

Mesh:

Substances:

Year:  2016        PMID: 27620744     DOI: 10.1007/s00432-016-2254-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  25 in total

1.  A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk.

Authors:  Elena Ratner; Lingeng Lu; Marta Boeke; Rachel Barnett; Sunitha Nallur; Lena J Chin; Cory Pelletier; Rachel Blitzblau; Renata Tassi; Trupti Paranjape; Pei Hui; Andrew K Godwin; Herbert Yu; Harvey Risch; Thomas Rutherford; Peter Schwartz; Alessandro Santin; Ellen Matloff; Daniel Zelterman; Frank J Slack; Joanne B Weidhaas
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

2.  Cancer incidences in rural Delhi--2004-05.

Authors:  N Manoharan; B B Tyagi; Vinod Raina
Journal:  Asian Pac J Cancer Prev       Date:  2010

3.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

4.  Association of Wnt signaling pathway genetic variants in gallbladder cancer susceptibility and survival.

Authors:  Anu Yadav; Annapurna Gupta; Saurabh Yadav; Neeraj Rastogi; Sushma Agrawal; Ashok Kumar; Vijay Kumar; Sanjeev Misra; Balraj Mittal
Journal:  Tumour Biol       Date:  2015-12-29

Review 5.  Epidemiology of digestive tract cancers in India IV. Gall bladder and pancreas.

Authors:  V Dhir; K M Mohandas
Journal:  Indian J Gastroenterol       Date:  1999 Jan-Mar

6.  Epidemiological Study of Gallbladder Cancer Patients from North Indian Gangetic Planes--a High-Volume Centre's Experience.

Authors:  Sameer Gupta; Channabasappa Kori; Vijay Kumar; Sanjeev Misra; Naseem Akhtar
Journal:  J Gastrointest Cancer       Date:  2016-03

Review 7.  No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Authors:  Antoinette Hollestelle; Frederieke H van der Baan; Andrew Berchuck; Sharon E Johnatty; Katja K Aben; Bjarni A Agnarsson; Kristiina Aittomäki; Elisa Alducci; Irene L Andrulis; Hoda Anton-Culver; Natalia N Antonenkova; Antonis C Antoniou; Carmel Apicella; Volker Arndt; Norbert Arnold; Banu K Arun; Brita Arver; Alan Ashworth; Laura Baglietto; Rosemary Balleine; Elisa V Bandera; Daniel Barrowdale; Yukie T Bean; Lars Beckmann; Matthias W Beckmann; Javier Benitez; Andreas Berger; Raanan Berger; Benoit Beuselinck; Maria Bisogna; Line Bjorge; Carl Blomqvist; Natalia V Bogdanova; Anders Bojesen; Stig E Bojesen; Manjeet K Bolla; Bernardo Bonanni; Judith S Brand; Hiltrud Brauch; Hermann Brenner; Louise Brinton; Angela Brooks-Wilson; Fiona Bruinsma; Joan Brunet; Thomas Brüning; Agnieszka Budzilowska; Clareann H Bunker; Barbara Burwinkel; Ralf Butzow; Saundra S Buys; Maria A Caligo; Ian Campbell; Jonathan Carter; Jenny Chang-Claude; Stephen J Chanock; Kathleen B M Claes; J Margriet Collée; Linda S Cook; Fergus J Couch; Angela Cox; Daniel Cramer; Simon S Cross; Julie M Cunningham; Cezary Cybulski; Kamila Czene; Francesca Damiola; Agnieszka Dansonka-Mieszkowska; Hatef Darabi; Miguel de la Hoya; Anna deFazio; Joseph Dennis; Peter Devilee; Ed M Dicks; Orland Diez; Jennifer A Doherty; Susan M Domchek; Cecilia M Dorfling; Thilo Dörk; Isabel Dos Santos Silva; Andreas du Bois; Martine Dumont; Alison M Dunning; Mercedes Duran; Douglas F Easton; Diana Eccles; Robert P Edwards; Hans Ehrencrona; Bent Ejlertsen; Arif B Ekici; Steve D Ellis; Christoph Engel; Mikael Eriksson; Peter A Fasching; Lidia Feliubadalo; Jonine Figueroa; Dieter Flesch-Janys; Olivia Fletcher; Annette Fontaine; Stefano Fortuzzi; Florentia Fostira; Brooke L Fridley; Tara Friebel; Eitan Friedman; Grace Friel; Debra Frost; Judy Garber; Montserrat García-Closas; Simon A Gayther; Aleksandra Gentry-Maharaj; Anne-Marie Gerdes; Graham G Giles; Rosalind Glasspool; Gord Glendon; Andrew K Godwin; Marc T Goodman; Martin Gore; Mark H Greene; Mervi Grip; Jacek Gronwald; Daphne Gschwantler Kaulich; Pascal Guénel; Starr R Guzman; Lothar Haeberle; Christopher A Haiman; Per Hall; Sandra L Halverson; Ute Hamann; Thomas V O Hansen; Philipp Harter; Jaana M Hartikainen; Sue Healey; Alexander Hein; Florian Heitz; Brian E Henderson; Josef Herzog; Michelle A T Hildebrandt; Claus K Høgdall; Estrid Høgdall; Frans B L Hogervorst; John L Hopper; Keith Humphreys; Tomasz Huzarski; Evgeny N Imyanitov; Claudine Isaacs; Anna Jakubowska; Ramunas Janavicius; Katarzyna Jaworska; Allan Jensen; Uffe Birk Jensen; Nichola Johnson; Arja Jukkola-Vuorinen; Maria Kabisch; Beth Y Karlan; Vesa Kataja; Noah Kauff; Linda E Kelemen; Michael J Kerin; Lambertus A Kiemeney; Susanne K Kjaer; Julia A Knight; Jacoba P Knol-Bout; Irene Konstantopoulou; Veli-Matti Kosma; Camilla Krakstad; Vessela Kristensen; Karoline B Kuchenbaecker; Jolanta Kupryjanczyk; Yael Laitman; Diether Lambrechts; Sandrina Lambrechts; Melissa C Larson; Adriana Lasa; Pierre Laurent-Puig; Conxi Lazaro; Nhu D Le; Loic Le Marchand; Arto Leminen; Jenny Lester; Douglas A Levine; Jingmei Li; Dong Liang; Annika Lindblom; Noralane Lindor; Jolanta Lissowska; Jirong Long; Karen H Lu; Jan Lubinski; Lene Lundvall; Galina Lurie; Phuong L Mai; Arto Mannermaa; Sara Margolin; Frederique Mariette; Frederik Marme; John W M Martens; Leon F A G Massuger; Christine Maugard; Sylvie Mazoyer; Lesley McGuffog; Valerie McGuire; Catriona McLean; Iain McNeish; Alfons Meindl; Florence Menegaux; Primitiva Menéndez; Janusz Menkiszak; Usha Menon; Arjen R Mensenkamp; Nicola Miller; Roger L Milne; Francesmary Modugno; Marco Montagna; Kirsten B Moysich; Heiko Müller; Anna Marie Mulligan; Taru A Muranen; Steven A Narod; Katherine L Nathanson; Roberta B Ness; Susan L Neuhausen; Heli Nevanlinna; Patrick Neven; Finn C Nielsen; Sune F Nielsen; Børge G Nordestgaard; Robert L Nussbaum; Kunle Odunsi; Kenneth Offit; Edith Olah; Olufunmilayo I Olopade; Janet E Olson; Sara H Olson; Jan C Oosterwijk; Irene Orlow; Nick Orr; Sandra Orsulic; Ana Osorio; Laura Ottini; James Paul; Celeste L Pearce; Inge Sokilde Pedersen; Bernard Peissel; Tanja Pejovic; Liisa M Pelttari; Jo Perkins; Jenny Permuth-Wey; Paolo Peterlongo; Julian Peto; Catherine M Phelan; Kelly-Anne Phillips; Marion Piedmonte; Malcolm C Pike; Radka Platte; Joanna Plisiecka-Halasa; Elizabeth M Poole; Bruce Poppe; Katri Pylkäs; Paolo Radice; Susan J Ramus; Timothy R Rebbeck; Malcolm W R Reed; Gad Rennert; Harvey A Risch; Mark Robson; Gustavo C Rodriguez; Atocha Romero; Mary Anne Rossing; Joseph H Rothstein; Anja Rudolph; Ingo Runnebaum; Ritu Salani; Helga B Salvesen; Elinor J Sawyer; Joellen M Schildkraut; Marjanka K Schmidt; Rita K Schmutzler; Andreas Schneeweiss; Minouk J Schoemaker; Michael G Schrauder; Fredrick Schumacher; Ira Schwaab; Giulietta Scuvera; Thomas A Sellers; Gianluca Severi; Caroline M Seynaeve; Mitul Shah; Martha Shrubsole; Nadeem Siddiqui; Weiva Sieh; Jacques Simard; Christian F Singer; Olga M Sinilnikova; Dominiek Smeets; Christof Sohn; Maria Soller; Honglin Song; Penny Soucy; Melissa C Southey; Christa Stegmaier; Dominique Stoppa-Lyonnet; Lara Sucheston; Anthony Swerdlow; Ingvild L Tangen; Muy-Kheng Tea; Manuel R Teixeira; Kathryn L Terry; Mary Beth Terry; Mads Thomassen; Pamela J Thompson; Laima Tihomirova; Marc Tischkowitz; Amanda Ewart Toland; Rob A E M Tollenaar; Ian Tomlinson; Diana Torres; Thérèse Truong; Helen Tsimiklis; Nadine Tung; Shelley S Tworoger; Jonathan P Tyrer; Celine M Vachon; Laura J Van 't Veer; Anne M van Altena; C J Van Asperen; David van den Berg; Ans M W van den Ouweland; Helena C van Doorn; Els Van Nieuwenhuysen; Elizabeth J van Rensburg; Ignace Vergote; Senno Verhoef; Robert A Vierkant; Joseph Vijai; Allison F Vitonis; Anna von Wachenfeldt; Christine Walsh; Qin Wang; Shan Wang-Gohrke; Barbara Wappenschmidt; Maren Weischer; Jeffrey N Weitzel; Caroline Weltens; Nicolas Wentzensen; Alice S Whittemore; Lynne R Wilkens; Robert Winqvist; Anna H Wu; Xifeng Wu; Hannah P Yang; Daniela Zaffaroni; M Pilar Zamora; Wei Zheng; Argyrios Ziogas; Georgia Chenevix-Trench; Paul D P Pharoah; Matti A Rookus; Maartje J Hooning; Ellen L Goode
Journal:  Gynecol Oncol       Date:  2015-05-02       Impact factor: 5.482

8.  The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer.

Authors:  Robert Pilarski; Divya A Patel; Jeffrey Weitzel; Terri McVeigh; Jemima J Dorairaj; Helen M Heneghan; Nicola Miller; Joanne B Weidhaas; Michael J Kerin; Megan McKenna; Xifeng Wu; Michelle Hildebrandt; Daniel Zelterman; Sharon Sand; Lee P Shulman
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

9.  KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study.

Authors:  Jasmina-Ziva Cerne; Vida Stegel; Ksenija Gersak; Srdjan Novakovic
Journal:  BMC Cancer       Date:  2012-03-22       Impact factor: 4.430

Review 10.  MicroRNA binding site polymorphisms as biomarkers in cancer management and research.

Authors:  Monica Cipollini; Stefano Landi; Federica Gemignani
Journal:  Pharmgenomics Pers Med       Date:  2014-07-23
View more
  6 in total

Review 1.  Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy.

Authors:  Alti Dayakar; Kumar D Shanmukha; Suresh K Kalangi
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.742

Review 2.  KRAS-related long noncoding RNAs in human cancers.

Authors:  Mahsa Saliani; Amin Mirzaiebadizi; Ali Javadmanesh; Akram Siavoshi; Mohammad Reza Ahmadian
Journal:  Cancer Gene Ther       Date:  2021-09-06       Impact factor: 5.854

3.  KRAS and VEGF gene 3'-UTR single nucleotide polymorphisms predicted susceptibility in colorectal cancer.

Authors:  Minnan Yang; Xiuli Xiao; Xiaorui Xing; Xin Li; Tian Xia; Hanan Long
Journal:  PLoS One       Date:  2017-03-22       Impact factor: 3.240

4.  microRNA Let-7b: A Novel treatment for endometriosis.

Authors:  Cagdas Sahin; Ramanaiah Mamillapalli; Kyong W Yi; Hugh S Taylor
Journal:  J Cell Mol Med       Date:  2018-07-31       Impact factor: 5.310

5.  From basic researches to new achievements in therapeutic strategies of KRAS-driven cancers.

Authors:  Mahsa Saliani; Razieh Jalal; Mohammad Reza Ahmadian
Journal:  Cancer Biol Med       Date:  2019-08       Impact factor: 4.248

Review 6.  Overview of current targeted therapy in gallbladder cancer.

Authors:  Xiaoling Song; Yunping Hu; Yongsheng Li; Rong Shao; Fatao Liu; Yingbin Liu
Journal:  Signal Transduct Target Ther       Date:  2020-10-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.